Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 CAD | -1.90% | -1.43% | -23.33% |
04-17 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
04-17 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- MarketScreener Editorial Features